Maximum Strength Acid Reducer Without prescription: NDMA impurity
Reason for Recall / Hazard
Product quality
Product Description & Identification
Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine.Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure.Contact your health care provider if you have taken a ranitidine product and you have concerns about your health.Report any health product adverse events or complaints to Health Canada.
Affected Products
Maximum Strength Acid Reducer Without prescription
Additional Source Details
| Field | Value |
|---|---|
| N I D | 63977 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/maximum-strength-acid-reducer-without-prescription-ndma-impurity |
| Issue | Product quality |
| Title | Maximum Strength Acid Reducer Without prescription: NDMA impurity |
| Product | Maximum Strength Acid Reducer Without prescription |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-03-11 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Talk to your doctor or pharmacist at your earliest convenience about alternative, non-ranitidine treatment options appropriate for your health circumstances. There are many prescription and over-the-counter drug alternatives in Canada that are authorized for the same or similar uses as ranitidine.Individuals taking a prescription ranitidine drug, including a recalled product, should not stop taking it unless they have spoken to their health care provider and obtained alternative treatment, as the risk of not treating the condition may be greater than the risk related to NDMA exposure.Contact your health care provider if you have taken a ranitidine product and you have concerns about your health.Report any health product adverse events or complaints to Health Canada. |